fashion -WSS

fashion

author：explore 2025-09-05 09:17:31 - browse：84466

gantenerumab Alzheimer's disease Roche — Sebastien Bozon/AFP via Getty Images

Roche said Monday it was buying Telavant Holdings for $7.1 billion upfront, picking up a promising experimental therapy for inflammatory bowel diseases.

Telavant is owned by Roivant Sciences, with Pfizer holding a minority stake. The deal will allow Roche to develop the therapy, called RVT-3101, and, pending approval, sell it in the United States and Japan. Pfizer holds the commercial rights in other parts of the world.

The “Roi” in Roivant stands for “return on investment” and with this deal, the biotech, founded by Republican presidential candidate Vivek Ramaswamy but now run by CEO Matt Gline, certainly delivered. Last December, it essentially acquired RVT-3101 from Pfizer for $45 million and a commitment to invest in the drug’s development. Less than a year later, Roivant flipped the drug to Roche for at least $7.1 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Heat waves linked to early deliveries, preterm births in new study

WSS

Timeline: How the deadly wildfires took over Maui day by day

Focused ultrasound for uterine fibroids: an uphill battle

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Treatments for cramps don't cut it. Why aren't there better options?

Idaho college killings prosecutors challenge defense's grand jury claims

Aspartame and sugar

Wikipedia

fashion

focus

BioMarin wins approval for gene therapy to treat hemophilia A

iTeos Therapeutics debuts first data on TIGIT

New air purifier tech could be key to improving indoor air quality

Health insurers say they are turning to AI to cut costs, improve care

23andMe had bad news about my health. I wish a person had delivered it

Montana youths win climate lawsuit against state for promoting fossil fuels

Medical records are filled with copy

Be careful with at

Activists slam private health insurers over coverage restrictions

What to know about the judge who will handle the Trump case

hotspot

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

Biden administration begins canceling student loan debt for 804,000 borrowers

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Dark money group runs ads on China biotech bill

Adam's Biotech Scorecard: Do Sarepta's exon

Biogen’s boardroom scandal saddles CEO with first crisis

focus

leisure time

hotspot

Wikipedia